1. St. Petersburg International Forum
Pharmacy. Medical Equipment. Biotechnology
THE OUTCOMES
St. Petersburg
April 25-27, 2012

2. IPhEB St. Petersburg International Forum
St. Petersburg International Forum IPhEB is the key event in Russia,
dedicated to strategic issues of innovative development of
pharmaceutical, biotechnological and medical industry.
The IPhEB 2012 Forum became one of the largest Russian events in the
scientific, technical and innovations sphere. The event was mainly focused
on elaboration of effective solutions for rapid development of Russian
pharmacy and medicine, creation, production and introduction of
innovative, high quality medications into clinical practice in order to
promote realization of state and private initiatives for development of
this extremely important sphere.
2

3. Aims of the Forum:
• To intensify contacts and experience exchange between the major
players of the market: heads and experts of companies manufacturing
medical or pharmaceutical products, R&D centers, health care
facilities; investment, financial and service companies;
• To attract investments to the market; tools and mechanisms of
dynamic innovative development;
• To introduce innovative technologies;
• To promote locally-manufactured products in international markets
3

4. Forum IPhEB 2012 is a multi-focused
business-oriented event with the following structure:
• Business programme in pharmacy, medicine and biotechnology.
• Exhibition of medical, pharmaceutical and laboratory equipment and
technology.
• The tour to Federal Service on Surveillance in Healthcare and Social
Development of the Russian Federation for medicines quality control.
• Marchmaking Center
• “Presentation zone” for innovative developments
• IPhEB Awards ceremony in nominations: Business project of the year,
Product of the year, IPhEB Science.
4

5. With the support of:
• The Ministry of Industry and Trade of the Russian Federation;
• The Chamber of Commerce and Industry of the Russian Federation;
• Plenipotentiary Representation of the President of the Russian Federation in the North-
Western Federal District;
• St. Petersburg City Administration
The Forum has gathered heads of executive authorities of all levels, rectors of the largest
domestic higher educational institutions and research centers, top managers and experts of
pharmacy companies, including MSD, Novartis, Novo-Nordisk, Stada, Philips, AstraZeneca
and others.
5

6. Target audience of the IPhEB 2012:
• The leading companies of medical Manufacture of pharmaceuticals, chemical and pharmaceutical industry
and pharmaceutical industry; Health facilities
Production and delivery of medical, pharmaceutical, laboratory, diagnostic and analytical
• The largest R&D institutions; equipment
R&D
• Relevant sector committees; Pharmacies
• Investors, financial institutions, Education
investment and insurance Financial institutions, investments (banks, venture funds, etc.)
Other
companies;
• Representatives of state power . 9%
4%
17%
6%
14%
23%
7%
20%
6

7. The Outcomes of the IPhEB-2012 Forum
IPhEB International Forum on pharmacy, medical industry and biotechnology was
successfully held in St. Petersburg, having gathered over 1,000 participants: heads of federal
and regional authorities, defining the industry development policy, the largest higher
educational institutions and research centers of the country, as well as companies from 18
regions of Russia and 15 countries.
Promotion of development of the pharmaceutical cluster in St. Petersburg;
Expert discussion of the development prospects in the pharmaceutical sector among more
than 1 000 participants;
Attraction of investment to the development of the pharmaceutical cluster;
7

8. The Forum business programme consisted of 13 topical
sessions and master classes on innovative development
of pharmaceutical and medical industry.
8

9. The plenary session
The plenary session National priorities
in pharmaceutical industry
development, held on the second day of
the Forum, was opened by Georgy
Poltavchenko, St. Petersburg Governor:
“I am glad to welcome the participants of
the International Forum which is the
best site to discuss the issues of
domestic pharmacy industry
development. This site creates
favourable conditions for a dialogue
between pharmacists, business and
authorities’. Georgy Poltavchenko
stressed that pharmacy is not only about
business, but also about work for the
sake of human well-being.
9

10. Sergey Tsyb, Director of department for chemical and technological
complex and bio-engineering technologies of the Ministry of
Industry and Trade of the Russian Federation
Sergey Tsyb in his speech summed up intermediate results of
implementing the federal target programme ‘Development Strategy
for Pharmaceutical and medical industry of the Russian Federation
for the period until 2020 and further outlook’ as one of the most
effective tools for complex industry transformation:
“St. Petersburg is demonstrating significant rates in terms of
innovative development of pharmacy and medical industry.
Attractive investment conditions have been created in the region.
The city itself – our northern capital – traditionally possesses the
most important resource for such a science-intensive industry as
medicine, namely it has human capital. Much has been done and is
still being done for the successful formation of one of the first
innovative medical and pharmaceutical clusters in Russia, which
presupposes the increase in shares of domestic pharmacy products,
improvement of their competitiveness and export opportunities.
Thus, the region has all prerequisites for successful implementation
of projects designed to create pharmaceutical enterprises as well as
research and development centers within the framework of the
PHARMA 2020 strategy”.
10

11. Panel discussion: Optimisation of pricing strategy for vital and
essential medicines: search for effective tools for sustainable
development of the Russian pharmaceutical market
During panel discussion, Dmitry Ter-Stepanov, Head of Department for Competition
Development, Ministry for Economic, Development of the Russian Federation, delivered a
speech. He informed that an inter-institutional group has been created which is intended to
elaborate price calculation method for new medications under supervision of Deputy
Minister Mikhail Oseevsky. According to his words, ‘current methods have become outdated
and if we keep using them, it may result in erosion of the whole medications groups from the
market, mainly the cheap ones, and the fact that the manufacturer has no opportunity to re-
register the price leads to the polymorphism in drugs (even the smallest change in the name
of pharmaceuticals by adding another definition or a slight replacement of the preparation
components allows to register a new price).
11

12. Round table Promotion of R&D in the sphere of pharmacy
and biotechnology
The round table attracted special attention
of the participants. Moderator Vitaly
Prutskiy, Head of R&D Information in
Russia and Eastern Europe, Head of Centre
for bio-informatics and predictive medicine
in St. Petersburg, set an active tempo to the
discussion, having told how quickly – “it
took AstraZeneca less than a year” – the
company managed to open a Center in St.
Petersburg, which will solve no only
regional tasks but also will serve the whole
world using local resources. Participants of
this round table focused their attention on
the opportunities and ambitions of Russian
R&D market.
12

13. Topical session International and regional cooperation in
the field of pharmacy and biotechnology
At the topical session, held on the second
day of the Forum, Zakhar Golant, Deputy
Chairman of Committee for Economic
Development, Industrial Policy and Trade
of St. Petersburg Government, emphasized
that the improvement of international
cooperation is necessary to develop the
whole region, therefore the Northern
capital attaches great importance to the
high quality meetings and events industry.
13

14. IPhEB award in the sphere of pharmacy and biotechnology
It is for the first time that an
IPhEB award in the sphere of
pharmacy and biotechnology was
established with the aim to
promote development of the latest
achievements in the sphere of
pharmaceutical, biotechnological
and medical technologies.
The awarding ceremony and
congratulations to the
laureates took place during gala
reception on behalf of Georgy
Poltavchenko, St. Petersburg
Governor on the occasion of the
Forum Opening.
14

15. IPhEB award in the sphere of pharmacy and biotechnology
Biocad with its product Genferone Light Spray became the winner in Product of
the year nomination. Dmitry Morozov, Chairman of the Board of Directors
received the award.
The nomination for Business project of the year was awarded to the Center of
protone radiation therapy of the Center of nuclear medicine at the
International Institute of Biologic Systems named after S.M. Berezin. The
award was handed to Georgy Andreev, Chief Medical Physicist of the company.
The center implements modern methods of nuclear medicine in clinical treatment
practice, prolongs lives of oncological patients as well.
IPhEB Science, a special personal award was honoured to Elena Shpakova – a
second year graduate student of RAS Institue of High-Molecular Compounds, for
the best work in the ‘Chemical synthesis of biologically active substances’ section.
15

16. Business Matchmaking Center
For three working days of Business
Matchmaking Center – a communication site
designed to establish new business and
partnership contacts – over 70 meetings were
registered.
The most significant negotiations were: a
meeting of representative of India Ministry of
pharmaceutical industry, the administration
of the UBM company (Great Britain) and
Zakhar Golant, Deputy Chairman of
Committee for Economic Development,
Industrial Policy and Trade, as well as the
meeting of FinnMedi company
representatives with Alexander Iova, Head of
the Chair of Neurology and Neurosurgery at
the Medical Academy of Post-Graduate
Education. The Business Matchmaking Center
became the major link between the Forum
participants and the exhibitors.
16

17. Exhibition of Medical Pharmaceutical and Laboratory Equipment
within the frameworks of IPhEB Forum
Another novelty of the Forum is the Exhibition of Medical Pharmaceutical and Laboratory
Equipment within the frameworks of IPhEB Forum, representing the latest achievements,
products and services in the sphere of medical, pharmaceutical and biotechnological
industry.
17

18. Exhibition of Medical Pharmaceutical and Laboratory Equipment
The exhibition was participated by the
largest Russian and foreign
companies, including PHARMEXCIL
(India), Favea, Khimexpert, Sartorius
IRC and others. A separate exposition
was formed by the companies,
members of St. Petersburg
pharmaceutical and medical industry
cluster – Novartis, MSD
Pharmaceuticals, Polysan, Samson-
Med, Geropharm, LDC MIBS
(Treatment and Diagnostics Center of
International Institute for Biological
systems) and NP Medical and
‘Pharmaceutical Projects. XXI century’.
18

19. Federal Service on Surveillance in Healthcare and Social Development
of the Russian Federation for medicines quality control.
A specialised tour took place within the frameworks of the business programme – the IPhEB
Forum participants visited a new Federal Service on Surveillance in Healthcare and Social
Development of the Russian Federation for medicines quality control.
It is located in the four-storey building and occupies total area of 2,700 sq.m. The
participants of this tour observed organisational department, analytical, microbiological and
pharmacological laboratories, where 48 high-grade experts work.
“You will not find such a laboratory anywhere in the city. Unique people work here”, Elena
Telnova, acting as head of Roszdravnadzor, assures, “there are only three laboratories of
such a high level in Russia: in Gudermes, Rostov-on-Don and Krasnoyarsk”. The plans include
opening of laboratories in Moscow and other cities. Within the nearest time, a mobile
express-laboratory on the basis of St. Petersburg laboratory complex for medicines quality
control will start working directly on the inspection facility: pharmacies, drugstores,
hospitals, clinics.
19

20. Testimonials
On the whole, as participants of the business programme and
exhibition exposition noted, the IPhEB Forum was held successfully.
Tatiana Mamaeva, Head of Regulatory
Department, National Center of
Expertise for Phramaceutical Products of
the Republic of Kazakhstan,
“I came from Kazakhstan to visit the
Forum for the first time. I have great
impressions from organisation,
discussions and topics. It is undoubtedly
an interesting and necessary event. The
most currently important topics of the
modern pharmaceutical industry,
exciting for the specialists of all
countries were discussed here. It is a
real platform for a dialogue. I wish I
could visit all the Forum events”.
20

21. Testimonials
Robert Rosen, Director General of Selecta
(RUS) Company, Bind (RUS):
‘It was a very interesting Forum. Such an
event contributes a lot to the future
development of science. The Forum lets us
understand and find one’s niche, find
research and administrative resources. The
Forum provides all the opportunities for
future successful work. Success comes with
clear purposes’.
21

22. Testimonials
Martin Schloh, Advisory in the sphere of
pharmacy and biotechnology at
PricewaterhouseCoopers:
“I would like to thank all event participants and
organisers. Special thanks to the Forum
interpreters. I saw energy and light in the
participants’ eyes’.
22

23. Testimonials
Sergey Smirnov, Board Chairman of Novo Nordisk LLC:
“St. Petersburg International Forum IPhEB left a very
favourable impression by its scale, organisation level,
number of participants and topics under discussion. I
learned a lot of useful information. A wonderful panel
discussion has just finished, where I made a report. And
yesterday a plenary session took place, where Georgy
Poltavchenko, St. Petersburg Governor, Sergey Tsyb,
Director of Department for chemical and technological
complex and bio-engineering technologies of the Ministry of Industry and
Trade of the Russian Federation, Elena Telnova, Deputy Head of Federal
Service for Supervision of Healthcare and Social Development took part.
Participation of such high officials also proves the Forum significance for the
Russian pharmacy and biotechnology”.
23

24. St. Petersburg International Forum
Pharmacy engineering
Medical equipment
Radiology
Biotechnology
St. Petersburg
April 10-11, 2013
24

25. The structure of the IPhEB -2013
St. Petersburg International Pharmacy Engineering and
Biotechnology Forum
International Medical Congress IMedR
International conference for medical radiology
Exhibition of pharmaceutical and
laboratory equipment and technology
Exhibition of medical equipment and
technics
25

26. St. Petersburg International Forum
Pharmacy engineering
Medical equipment
Radiology
Biotechnology
St. Petersburg
April 10-11, 2013